Certain Options of GoodRx Holdings, Inc. are subject to a Lock-Up Agreement Ending on 22-MAR-2021.
March 21, 2021
Share
Certain Options of GoodRx Holdings, Inc. are subject to a Lock-Up Agreement Ending on 22-MAR-2021. These Options will be under lockup for 181 days starting from 22-SEP-2020 to 22-MAR-2021.
Details:
The company, directors, officers and the holders of substantially all of outstanding stock and stock options have agreed that the will not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock for a period of 180 days after the date of the final prospectus without the prior written consent of the representatives on behalf of the underwriters.
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.